1,414 results on '"Roupret, M"'
Search Results
2. Basal/squamous and mixed subtype bladder cancers present poor outcomes after neoadjuvant chemotherapy in the VESPER trial
3. Erdafitinib in BCG-treated high-risk non-muscle-invasive bladder cancer
4. Détection précoce du cancer de la prostate : vers un nouveau paradigme ?
5. Les grands principes des traitements du cancer de prostate localisé
6. Résultats des cures de varicocèles microchirurgicales sous-inguinales
7. Tumori renali
8. Litiasis urinaria: tratamiento en urología
9. Photodynamic cystoscopy for bladder cancer diagnosis and for NMIBC follow-up: An overview of systematic reviews and meta-analyses
10. Ureteropelvic junction obstruction and renal calculi: Simultaneous treatment by robot-assisted laparoscopic pyeloplasty and transcutaneous retrograde flexible ureteroscopy. Technique description and early outcomes
11. L’évolution et le devenir des oncocytomes biopsiés surveillés
12. Envahissement ganglionnaire pelvien anatomopathologique après cystectomie totale pour le traitement des tumeurs de vessie infiltrant le muscle : une revue narrative de la littérature
13. Validation linguistique française du questionnaire SSIPI évaluant la satisfaction des patients porteurs d’une prothèse pénienne
14. Tumor de la vía excretora superior
15. Biochemical relapse predictive factors in patients with lymph node metastases during radical prostatectomy
16. French AFU Cancer Committee Guidelines - Update 2022-2024: testicular germ cell cancer
17. French AFU Cancer Committee Guidelines - Update 2022-2024: penile cancer
18. French AFU Cancer Committee Guidelines Update 2022–2024: Adrenal tumor – Assessment of an adrenal incidetaloma and oncological management
19. French AFU Cancer Committee Guidelines - Update 2022-2024: prostate cancer - Diagnosis and management of localised disease
20. French AFU Cancer Committee Guidelines – Update 2022–2024: Upper urinary tract urothelial cancer (UTUC)
21. French AFU Cancer Committee Guidelines - Update 2022-2024: Non-muscle-invasive bladder cancer (NMIBC)
22. French AFU Cancer Committee Guidelines - Update 2022-2024: prostate cancer - Management of metastatic disease and castration resistance
23. French AFU Cancer Committee Guidelines - Update 2022-2024: management of kidney cancer
24. French AFU Cancer Committee Guidelines – Update 2022–2024: Muscle-Invasive Bladder Cancer (MIBC)
25. Avancées récentes dans la prise en charge du cancer de la prostate localisé à haut risque : mise au point par le Comité Prostate de l’Association française d’urologie
26. Interesse dello screening del cancro della prostata
27. Trattamento conservativo dei tumori della via escretrice superiore
28. Sindrome del dolore vescicale (o cistite interstiziale)
29. Recommandations du Comité de cancérologie de l’Association Française d’Urologie (CC-AFU) pour la bonne pratique des instillations intravésicales de mitomycine C, d’épirubicine et de BCG pour le traitement des tumeurs de la vessie n’infiltrant pas le muscle (TVNIM)
30. Instauration du traitement adjuvant endovésical par épirubicine des tumeurs de vessie n’infiltrant pas le muscle : premier retour national d’expérience du CC-AFU vessie
31. Tratamiento conservador de los tumores de la vía excretora superior
32. Recherche d’altérations des gènes de réparation de l’ADN dans le cancer de la prostate : mise au point pratique du Comité de cancérologie de l’association française d’urologie
33. Recommandations des Comités de cancérologie (CC-AFU) et d’infectiologie (CI-AFU) de l’Association française d’urologie pour la prise en charge effets indésirables et complications du BCG
34. Positive environmental impact of remote teleconsultation in urology during the COVID-19 pandemic in a highly populated area
35. Efficacité et tolérance des traitements locaux en injections pour le traitement de la maladie de La Peyronie : revue de la littérature
36. Oncologic outcomes in patients with variant histologies of upper tract urothelial cancer: Results from an international multicenter cohort
37. Clinical Application of Bladder MRI and Vesical Imaging-Reporting And Data System
38. Evaluation of the long term recurrence risk, metastatic potential and length of cystoscopic surveillance of low-grade non-muscle invasive bladder cancer
39. Management and predictive factors of unplanned open conversion during minimally invasive renal tumor surgery
40. Consistencies in follow-up after radical cystectomy for bladder cancer: A practice-based framework by collaborative EAU bladder cancer guideline panels
41. Thromboprophylaxis during neoadjuvant chemotherapy before cystectomy is associated with a lower risk of venous thromboembolism and bleeding, a multicentric retrospective study
42. Stage-specific recurrence rates post-radical cystectomy: A path to personalized oncological follow-up
43. Individual patient data validation of the definitions of BCG failure in patients with non-muscle invasive urothelial carcinoma of the bladder: An international multi-centre retrospective study
44. Towards defining follow-up strategies for patients with primary (first diagnosis) EAU2021 intermediate-risk non-muscle invasive bladder cancer
45. Impact of volume difference between 3D transrectal ultrasound and MRI segmentation on the outcome of fusion MRI-Targeted prostate biopsy
46. Interleukin-6 and its soluble receptor as predictors of disease outcomes after radical nephroureterectomy in patients with upper tract urothelial carcinoma
47. A novel PRECISE implemented predictive model to assess the risk of long-term disease reclassification in men on active surveillance. Results from a large, single institution series
48. Towards a tailored use of PSA density to decide when to avoid prostate biopsy in men with PIRADS 3 lesions according to the location of the index lesion at mp-MRI. Results of a large, multi-institutional series
49. Nouveautés dans la chirurgie des cancers de la prostate localisés de haut risque
50. Pieloplastica laparoscopica robot-assistita
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.